Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria
This study is ongoing, but not recruiting participants.
Sponsor:
Mayo Clinic
Collaborators:
Oxalosis and Hyperoxaluria Foundation (OHF)
Information provided by:
Mayo Clinic
ClinicalTrials.gov Identifier:
NCT00588120
First received: December 26, 2007
Last updated: June 19, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
![](https://webarchive.library.unt.edu/web/20121019031205im_/http://www.clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
The purpose of this study is to learn more about a condition called 'unclassified hyperoxaluria'. People with this condition have large amounts of oxalate (a salt) in their urine, which can cause kidney stones and kidney failure. We do not know what causes the high level of oxalate in the urine. In this study, we will examine how oxalate in the diet affects this condition. We will compare the results of affected patients to healthy volunteers.
Condition | Intervention |
---|---|
Enteric Hyperoxaluria Unclassified Hyperoxaluria |
Drug: 13C-oxalate Drug: C-13 Oxalate |
Study Type: | Interventional |
Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
Official Title: | Investigations Into the Genotype and Phenotype of Unclassified Hyperoxaluria: Enteric Oxalate Absorption Study |
Resource links provided by NLM:
Further study details as provided by Mayo Clinic:
Primary Outcome Measures:
- To gain knowledge on how oxalate in the diet affects Enteric Hyperoxaluria [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Estimated Enrollment: | 125 |
Study Start Date: | December 1998 |
Estimated Study Completion Date: | October 2012 |
Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Experimental: C-13 Oxalate dose
Hyperoxaluric patients
|
Drug: 13C-oxalate
13C Oxalate (Jell-O) Take Jell-O by mouth for one day. 13C Oxalate (Capsule) Take one capsule by mouth for one day.
Other Name: C-13 Oxalate
Drug: C-13 Oxalate
Participants oxalate intake and output will be monitored and assessed over a 24 hour period. Participants will ingest a prescribed C-13 oxalate dose and urine oxalate will be monitored for the 24 hour study period.
|
Detailed Description:
Participants' oxalate intake and output will be monitored and assessed over a 24 hour period. Participants will ingest a prescribed oxalate dose and urine oxalate will be monitored for the 24 hour study period.
![](https://webarchive.library.unt.edu/web/20121019031205im_/http://www.clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Ages Eligible for Study: | 4 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Age equal to or greater than 4 years (patient must be able to void on request).
- Have good health.
Exclusion Criteria:
- Any prior history of renal disease, or hypertension
- ALL subjects (controls and affected patients) will be asked to discontinue any diuretics, calcium supplements, H2 blockers, proton pump inhibitors or gastrointestinal motility agents for approximately one week prior to initiation of the study.
- Subjects with GFR < 50 cc/min will be excluded.
![](https://webarchive.library.unt.edu/web/20121019031205im_/http://www.clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00588120
Locations
United States, Minnesota | |
Mayo Clinic Rochester | |
Rochester, Minnesota, United States, 55905 |
Sponsors and Collaborators
Mayo Clinic
Oxalosis and Hyperoxaluria Foundation (OHF)
Investigators
Principal Investigator: | Dawn Milliner | Mayo Clinic |
![](https://webarchive.library.unt.edu/web/20121019031205im_/http://www.clinicaltrials.gov/ct2/html/images/frame/triangle.gif)
Additional Information:
No publications provided
Responsible Party: | Dr. Dawn Milliner, Mayo Clinic |
ClinicalTrials.gov Identifier: | NCT00588120 History of Changes |
Other Study ID Numbers: | 1026-98, RFA-OD-08-001, 1U54DK083908-01 |
Study First Received: | December 26, 2007 |
Last Updated: | June 19, 2012 |
Health Authority: | United States: Institutional Review Board |
Keywords provided by Mayo Clinic:
Hyperoxaluria Unknown Hyperoxaluria Enteric Hyperoxaluria Oxaluric |
High Oxalate Oxalate C13 Oxalate Diet |
Additional relevant MeSH terms:
Hyperoxaluria Kidney Diseases Urologic Diseases |
ClinicalTrials.gov processed this record on October 17, 2012